The primary means of communication between neurons in the mammalian central
nervous system (CNS) is via release of chemical transmitters. Although the
first transmitters to be discovered were the biogenic amines, such as acet
ylcholine and norepinephrine, involved in transmission in the autonomic ner
vous system, the contribution of other types of transmitters, such as amino
acids and peptides, to CNS transmission has been the subject of recent stu
dy. Part of this interest stems from the relatively large percentage of neu
ronal connections that make use of amino acid transmitters such as gamma-am
inobutyric acid and glutamate and also from the tremendous diversity possib
le when peptides are used as transmitters. Several disorders of CNS transmi
ssion are related to the degeneration of neuronal pathways in the brain. Tw
o of the most prevalent neurologic disorders that result from degeneration
are Alzheimer's and Parkinson's diseases. Aspects of these disorders relate
d to chemical neurotransmission are discussed, along with implications with
regard to therapeutic strategies. Functions of and possible abnormalities
in amino acid transmission that may be associated with CNS disorders are ex
amined. Several peptides are postulated to play a role in neurotransmission
and concepts regarding the significance of the coexistence and release of
biogenic amines and peptides at the same neuronal terminals are presented.